6 Insights on “PECAN” by Vincent Erdmann

In “6 Insights on PECAN” our PECAN expert Vincent Erdmann answers the most relevant questions of the PECAN process in France.

7 Insights on DiGA by Alexander Voigt

In “7 Insights on DiGA”, our DiGA expert Alexander Voigt provides answers to the most relevant questions about DiGA.

DiGA in Pharma: Everything You Need To Know Now.

In an extensive article in PM-Report, Germany’s most significant pharma magazine, Digital Oxygen’s experts provide a 360° overview of DiGA in the context of pharma.

DiGA Iceberg: The unknown number of DiGA prescriptions

One aspect of DiGA is frequently left out in recent reports: The unknown number of DiGA prescriptions – the part of the DiGA iceberg that is not visible.

DiGA Canvas 2023

The DiGA Canvas is a comprehensive tool to assess the crucial questions, challenges, and requirements for your DiGA.

Pharma and the 4D – Opportunity or Threat?

In this article, Torsten Christann comments on the importance, opportunities, and downsides of data for the pharma industry’s future business models.

DiGA Partnerships: Start-ups Meet Corporates

There is a trend of DiGA start-ups looking for corporate partners and vice versa. But why?

Self-Measurement as Opportunity for Real-World-Evidence in Market Access

Sensors, wearables, apps: Torsten Christann comments on the opportunities of self-measurement for the generation of Real-World-Evidence in Market Access processes.

Apps On Prescription and Big Pharma: A Beneficial Combination?

In this article, Torsten Christann addresses the question whether pharma corporations should add DiGA to their portfolio or no.

Enduring DiGA Success: Reaching Patients After Market Access

At WIG2 Digital Health Conference, Healthcare Expert Alexander Voigt talked about what matters after the regulatory market access: Reaching patients.